Literature DB >> 11251484

Cesarean delivery in Shantou, China: a retrospective analysis of 1922 women.

W L Wu1.   

Abstract

BACKGROUND: In China the cesarean section rate increased significantly during the past four decades. This study examined the frequency and indications of cesarean birth in Shantou, a southern city in China.
METHODS: An analysis was conducted of the medical records of 1922 women who had cesarean deliveries at Shantou City 2nd People's Hospital between January 1990 and December 1997. The medical records of 10,490 women who gave birth during this period were examined.
RESULTS: The average rate of cesarean delivery during the 8-year period was 19.4 +/- 2.3 percent (means +/- standard error). From 1990 to 1997 the cesarean delivery rates ranged from 11.05 to 29.9 percent, respectively, although during this period the total annual number of deliveries decreased significantly from 1683 to 951. The rates of the most common indications per 100 women for cesarean delivery were failure to progress (23%), premature rupture of membranes (20%), fetal distress (19.4%), breech presentation (18.1%), uterine scar (14.6%), and prolonged pregnancy (11.3%).
CONCLUSION: The cesarean delivery rate in Shantou, China, has increased steadily and significantly between 1990 and 1997, despite a decrease in the total number of births during the same period. This study showed that on an individual basis vaginal delivery was often possible and reduction of the cesarean delivery rate could be achieved safely by paying greater heed to appropriate indications.

Entities:  

Mesh:

Year:  2000        PMID: 11251484     DOI: 10.1046/j.1523-536x.2000.00086.x

Source DB:  PubMed          Journal:  Birth        ISSN: 0730-7659            Impact factor:   3.689


  8 in total

1.  Declining fertility and the use of cesarean delivery: evidence from a population-based study in Taiwan.

Authors:  Ke-Zong M Ma; Edward C Norton; Shoou-Yih D Lee
Journal:  Health Serv Res       Date:  2010-10       Impact factor: 3.402

2.  Delivery settings and caesarean section rates in China.

Authors:  Guo Sufang; Sabu S Padmadas; Zhao Fengmin; James J Brown; R William Stones
Journal:  Bull World Health Organ       Date:  2007-10       Impact factor: 9.408

3.  Practice audits to reduce caesareans in a tertiary referral hospital in south-western China.

Authors:  Ma Runmei; Lao Terence T; Sun Yonghu; Xiao Hong; Tian Yuqin; Li Bailuan; Yang Minghui; Yang Weihong; Liang Kun; Liang Guohua; Li Hongyu; Geng Li; Ni Renmin; Qi Wenjin; Chen Zhuo; Du Mingyu; Zhu Bei; Xu Jing; Tao Yanping; Zhang Lan; Song Xianyan; Qu Zaiqing; Sun Qian; Yi Xiaoyun; Yu Jihui; Zhang Dandan
Journal:  Bull World Health Organ       Date:  2012-03-13       Impact factor: 9.408

4.  A Segmented Logistic Regression Approach to Evaluating Change in Caesarean Section Rate with Reform of Birth Planning Policy in Two Regions in China from 2012 to 2016.

Authors:  Lili Kang; Shangyuan Ye; Kangzhen Jing; Yancun Fan; Qihui Chen; Ning Zhang; Bo Zhang
Journal:  Risk Manag Healthc Policy       Date:  2020-03-19

5.  Caesarean deliveries in China.

Authors:  Xin Wang; Susan Hellerstein; Lei Hou; Liying Zou; Yan Ruan; Weiyuan Zhang
Journal:  BMC Pregnancy Childbirth       Date:  2017-02-06       Impact factor: 3.007

6.  Normal labor curve is affected by fetus gender: A cohort study.

Authors:  Mandana Rashidi Meibodi; Elaheh Mossayebi; Zahra Najmi; Yousef Moradi
Journal:  Med J Islam Repub Iran       Date:  2017-12-17

Review 7.  Cesarean section in the People's Republic of China: current perspectives.

Authors:  Xing Lin Feng; Ying Wang; Lin An; Carine Ronsmans
Journal:  Int J Womens Health       Date:  2014-01-09

8.  The trend of caesarean birth rate changes in China after 'universal two-child policy' era: a population-based study in 2013-2018.

Authors:  Jie Yan; Long Wang; Ying Yang; Ya Zhang; Hongguang Zhang; Yuan He; Zuoqi Peng; Yuanyuan Wang; Qiaomei Wang; Haiping Shen; Yiping Zhang; Donghai Yan; Xu Ma; Huixia Yang
Journal:  BMC Med       Date:  2020-09-15       Impact factor: 8.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.